Factor XIII Inhibitor Screen
Factor XIII is a coagulation protein that plays an important role in the stabilisation of a fibrin clot. Patients with FXIII deficiency can be treated with FXIII concentrate. It is possible that a patient can develop an antibody to the FXIII concentrate, thus affecting the efficacy of treatment.This test is used to screen for such antibodies.
| Tube | 05 (CP) - Citrate |
|---|---|
| ID | 12638 |
| Availability | Weekly |
| Additional Information | Uses a Bethesda method read spectrophotometrically. |
| Turn Around | 10 days |
| Send to | Specialist Coagulation Chancellor / Lincoln Wing Link Corridor Pathology Block 32 St James University Hospital Beckett Street Leeds LS9 7TF |
| Contact | https://www.leedsth.nhs.uk/a-z-of-services/pathology-2/specialist-laboratory-medicine-slm/specialist-coagulation/?stage=Stage |
| Collection Con | 2 x Citrate tubes filled to line please. Samples must be received & frozen within 6 hours of being taken. |
| Sample REQ | Blood |
| Ref. Range Notes | If no inhibitor detected, this will be reported as NOT DETECTED. If present a bethesda unit will be reported |
| Units | Bethesda Units (BU) |
| Telepath | F13I1J |
| ICE Codes | LF13I |
